Considerable information is currently available from neuroimaging, pathological, and
population-based prospective studies showing that vascular risk factors are independently …

Alzheimer's disease (AD) is a well-known neurodegenerative disease characterized by the
presence of two main hallmarks–Tau hyperphosphorylation and Aβ deposits …

Objectives: The aim of this study was to determine whether use of diuretics, angiotensin-1
receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACE-I), calcium channel …

Hypertension is an established risk factor for cognitive decline and dementia in older adults,
highlighting the potential importance of antihypertensive treatments in prevention efforts …

There is wide recognition of a complex association between midlife hypertension and
cardiovascular disease and later development of Alzheimer's disease (AD) and cognitive …

The clinical syndrome of heart failure is one of the leading causes of hospitalisation and
mortality in older adults. An association between cognitive impairment and heart failure is …

Objectives There is growing evidence that antihypertensive agents, particularly centrally
acting ACE inhibitors (CACE-Is), which cross the blood–brain barrier, are associated with a …

A quantitative meta-analysis was performed to evaluate the association of renin-angiotensin
system blockade (RASB) use with the incidence of cognitive impairment of aging and …

Vascular risk factors have been associated with cognitive deficits and incident dementia in
the general population, but their role on cognitive dysfunction in Parkinson's disease (PD) is …

Angiotensin converting enzyme (ACE) converts Angiotensin I to a potent vasoconstrictor
angiotensin II (ANG II). ACE inhibitors (ACEIs) are widely used for the management of …